Lexaria Bioscience Statistics
Total Valuation
LEXX has a market cap or net worth of $21.56 million. The enterprise value is $17.23 million.
Important Dates
The next estimated earnings date is Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LEXX has 24.89 million shares outstanding. The number of shares has increased by 34.21% in one year.
| Current Share Class | 24.89M |
| Shares Outstanding | 24.89M |
| Shares Change (YoY) | +34.21% |
| Shares Change (QoQ) | +9.19% |
| Owned by Insiders (%) | 4.07% |
| Owned by Institutions (%) | 6.88% |
| Float | 23.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.29 |
| Forward PS | n/a |
| PB Ratio | 3.92 |
| P/TBV Ratio | 4.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 33.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.68 |
| Quick Ratio | 3.10 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -155.23% and return on invested capital (ROIC) is -92.90%.
| Return on Equity (ROE) | -155.23% |
| Return on Assets (ROA) | -82.96% |
| Return on Invested Capital (ROIC) | -92.90% |
| Return on Capital Employed (ROCE) | -228.90% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | $74,571 |
| Profits Per Employee | -$1.54M |
| Employee Count | 7 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LEXX has paid $1,791 in taxes.
| Income Tax | 1,791 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.35% in the last 52 weeks. The beta is 0.56, so LEXX's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -49.35% |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 66.41 |
| Average Volume (20 Days) | 155,226 |
Short Selling Information
The latest short interest is 373,096, so 1.50% of the outstanding shares have been sold short.
| Short Interest | 373,096 |
| Short Previous Month | 383,896 |
| Short % of Shares Out | 1.50% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 2.72 |
Income Statement
In the last 12 months, LEXX had revenue of $522,000 and -$10.79 million in losses. Loss per share was -$0.56.
| Revenue | 522,000 |
| Gross Profit | 522,000 |
| Operating Income | -10.52M |
| Pretax Income | -10.80M |
| Net Income | -10.79M |
| EBITDA | -10.44M |
| EBIT | -10.52M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $4.42 million in cash and $101,920 in debt, with a net cash position of $4.32 million or $0.17 per share.
| Cash & Cash Equivalents | 4.42M |
| Total Debt | 101,920 |
| Net Cash | 4.32M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 4.52M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.71 million and capital expenditures -$1, giving a free cash flow of -$8.71 million.
| Operating Cash Flow | -8.71M |
| Capital Expenditures | -1 |
| Depreciation & Amortization | 71,496 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.71M |
| FCF Per Share | -$0.35 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -2,014.62% |
| Pretax Margin | -2,069.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LEXX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.21% |
| Shareholder Yield | -34.21% |
| Earnings Yield | -50.07% |
| FCF Yield | -40.40% |
Analyst Forecast
The average price target for LEXX is $1.50, which is 73.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.50 |
| Price Target Difference | 73.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 187.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 12, 2021. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 12, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
LEXX has an Altman Z-Score of -10.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.3 |
| Piotroski F-Score | 2 |
